CD8A and COVID-19: In SARS-CoV-2 infection, also the high levels of virus-specific CD8 + T-cells have been associated with better COVID-19 outcomes, producing high levels of molecules with potent cytotoxic effector functions, such as IFN-γ, granzyme B, perforin, and CD107a [15, 16, 19].